Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity
scientific article published in July 2004
Author/s
author: Paul G. Richardson, Kenneth C. Anderson, Robert Douglas Knight, Teru Hideshima, Constantine S Mitsiades, Robert Schlossman, Andrea Freeman, Jerome B Zeldis, Sundar Jagannath, Melissa Alsina, Faith E Davies
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.